As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas.

Ipsen : 2018 financial objectives

Group sales growth

> 16.0%

Core operating margin

> 28.0%

Ipsen : H1 2017 financial results